Form 4 for ANRO Alto Neuroscience, Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0002007795-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-03-01 | ANRO | Etkin Amit | Pres AND CEO, Dir | F - Tax | $19.69 | -6,227 | 1.23M | -0.5% | -$122.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | F | D | 6,227 | $19.69 | 1,233,949 | D | — | — | (F1) Represents shares of common stock withheld for payment of taxes upon vesting of restricted stock units previously reported in Table I and does not represent an open market transaction by the reporting person. |